Literature DB >> 22028624

Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.

Aurélie Coulon1, Marjorie Flahaut, Annick Mühlethaler-Mottet, Roland Meier, Julie Liberman, Katia Balmas-Bourloud, Katya Nardou, Pu Yan, Stéphane Tercier, Jean-Marc Joseph, Lukas Sommer, Nicole Gross.   

Abstract

Neuroblastoma (NB) is a neural crest-derived childhood tumor characterized by a remarkable phenotypic diversity, ranging from spontaneous regression to fatal metastatic disease. Although the cancer stem cell (CSC) model provides a trail to characterize the cells responsible for tumor onset, the NB tumor-initiating cell (TIC) has not been identified. In this study, the relevance of the CSC model in NB was investigated by taking advantage of typical functional stem cell characteristics. A predictive association was established between self-renewal, as assessed by serial sphere formation, and clinical aggressiveness in primary tumors. Moreover, cell subsets gradually selected during serial sphere culture harbored increased in vivo tumorigenicity, only highlighted in an orthotopic microenvironment. A microarray time course analysis of serial spheres passages from metastatic cells allowed us to specifically "profile" the NB stem cell-like phenotype and to identify CD133, ABC transporter, and WNT and NOTCH genes as spheres markers. On the basis of combined sphere markers expression, at least two distinct tumorigenic cell subpopulations were identified, also shown to preexist in primary NB. However, sphere markers-mediated cell sorting of parental tumor failed to recapitulate the TIC phenotype in the orthotopic model, highlighting the complexity of the CSC model. Our data support the NB stem-like cells as a dynamic and heterogeneous cell population strongly dependent on microenvironmental signals and add novel candidate genes as potential therapeutic targets in the control of high-risk NB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22028624      PMCID: PMC3201575          DOI: 10.1593/neo.11800

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  76 in total

Review 1.  Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation.

Authors:  Anders Edsjö; Linda Holmquist; Sven Påhlman
Journal:  Semin Cancer Biol       Date:  2006-05-10       Impact factor: 15.707

2.  Stem cells and cancer: two faces of eve.

Authors:  Michael F Clarke; Margaret Fuller
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

3.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

4.  Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.

Authors:  Marjorie Flahaut; Annick Mühlethaler-Mottet; Danielle Martinet; Sarah Fattet; Katia Balmas Bourloud; Katya Auderset; Roland Meier; Nathalie Besuchet Schmutz; Olivier Delattre; Jean-Marc Joseph; Nicole Gross
Journal:  Genes Chromosomes Cancer       Date:  2006-05       Impact factor: 5.006

5.  Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells.

Authors:  Carla Bänziger; Davide Soldini; Corina Schütt; Peder Zipperlen; George Hausmann; Konrad Basler
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

6.  p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres.

Authors:  Pasquale Sansone; Gianluca Storci; Catia Giovannini; Silvia Pandolfi; Simona Pianetti; Mario Taffurelli; Donatella Santini; Claudio Ceccarelli; Pasquale Chieco; Massimiliano Bonafé
Journal:  Stem Cells       Date:  2006-12-07       Impact factor: 6.277

7.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

8.  Identification and expansion of human colon-cancer-initiating cells.

Authors:  Lucia Ricci-Vitiani; Dario G Lombardi; Emanuela Pilozzi; Mauro Biffoni; Matilde Todaro; Cesare Peschle; Ruggero De Maria
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

9.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

Authors:  Dagmar Beier; Peter Hau; Martin Proescholdt; Annette Lohmeier; Jörg Wischhusen; Peter J Oefner; Ludwig Aigner; Alexander Brawanski; Ulrich Bogdahn; Christoph P Beier
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

10.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

View more
  38 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ghada Abu Elghanam; Xinyun Su; Younan Liu; Peter J Chauvin; Simon D Tran
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

4.  Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.

Authors:  Sharada D Vangipuram; Steven A Buck; William D Lyman
Journal:  Tumour Biol       Date:  2012-08-11

5.  G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Authors:  Danielle M Hsu; Saurabh Agarwal; Ashley Benham; Cristian Coarfa; Denae N Trahan; Zaowen Chen; Paris N Stowers; Amy N Courtney; Anna Lakoma; Eveline Barbieri; Leonid S Metelitsa; Preethi Gunaratne; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2013-05-16       Impact factor: 12.701

6.  Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.

Authors:  Serena Vella; Ilaria Penna; Luca Longo; Giulia Pioggia; Patrizia Garbati; Tullio Florio; Fabio Rossi; Aldo Pagano
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

7.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

8.  CD271 defines a stem cell-like population in hypopharyngeal cancer.

Authors:  Takayuki Imai; Keiichi Tamai; Sayuri Oizumi; Kyoko Oyama; Kazunori Yamaguchi; Ikuro Sato; Kennichi Satoh; Kazuto Matsuura; Shigeru Saijo; Kazuo Sugamura; Nobuyuki Tanaka
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 9.  Bone Marrow Environment in Metastatic Neuroblastoma.

Authors:  Chiara Brignole; Fabio Pastorino; Patrizia Perri; Loredana Amoroso; Veronica Bensa; Enzo Calarco; Mirco Ponzoni; Maria Valeria Corrias
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

10.  p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.

Authors:  B Marengo; C G De Ciucis; R Ricciarelli; A L Furfaro; R Colla; E Canepa; N Traverso; U M Marinari; M A Pronzato; C Domenicotti
Journal:  Cell Death Dis       Date:  2013-04-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.